Riggs Rory B
- SEC CIK
- 0001016835
No open-market purchases or sales filed in the past year.
Current role at each company
- CBUS Cibus, Inc.Directoras of Jun 4, 2026
- ITCI Intra-Cellular Therapies, Inc.Directoras of Apr 2, 2025
- RPRX Royalty Pharma plcDirectoras of Feb 22, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Riggs Rory B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ITCI Intra-Cellular Therapies, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2022 (view filing) | Mar 16-18 | 2 days | Riggs Rory BDirector | SSale | −226.7K | $60.11 | −$13.6M | −100.0%0 after | 6 lots |
| Jun 25, 2024 (view filing) | Jun 24 | 1 day | Riggs Rory BDirector | SSale | −4.46K | $75.57 | −$337.2K | −3.7%116.6K after |
RPRX Royalty Pharma plc
Director17 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2021 (view filing) | Sep 28-29 | 2 days | Riggs Rory BDirector | SSaleClass A Ordinary Shares | −64.6K | $36.65 | −$2.37M | −9.5%615.1K after | 2 lots |
| Sep 30, 2021 (view filing) | Sep 29 | 1 day | Riggs Rory BDirector | SSaleClass A Ordinary Shares | −63.8K | $36.35 | −$2.32M | −3.0%2.07M after | 3 lots |
| Nov 18, 2021 (view filing) | Nov 16-17 | 2 days | Riggs Rory BDirector | SSaleClass A Ordinary Shares | −75.0K | $42.33 | −$3.17M | −10.8%622.4K after | 2 lots |
| Nov 18, 2021 (view filing) | Nov 17 | 1 day | Riggs Rory BDirector | SSaleClass A Ordinary Shares | −139.4K | $42.35 | −$5.90M | −11.1%1.12M after | 3 lots |
| Dec 30, 2021 (view filing) | Dec 28 | 2 days | Riggs Rory BDirector | SSaleClass A Ordinary Shares | −109.4K | $40.21 | −$4.40M | −14.0%673.1K after | 3 lots |
| Dec 30, 2021 (view filing) | Dec 29 | 1 day | Riggs Rory BDirector | SSaleClass A Ordinary Shares | −75.0K | $40.00 | −$3.00M | −11.2%592.7K after | |
| Mar 21, 2022 (view filing) | Mar 18-21 | 3 days | Riggs Rory BDirector | SSaleClass A Ordinary Shares | −169.1K | $39.43 | −$6.67M | −100.0%0 after | 5 lots |
| Mar 30, 2022 (view filing) | Mar 29 | 1 day | Riggs Rory BDirector | SSaleClass A Ordinary Shares | −60.0K | $38.59 | −$2.32M | −9.1%601.7K after | |
| May 23, 2022 (view filing) | May 19-20 | 4 days | Riggs Rory BDirector | SSaleClass A Ordinary Shares | −150.0K | $39.42 | −$5.91M | −24.9%451.7K after | 2 lots |
| Jun 29, 2022 (view filing) | Jun 29 | Same day | Riggs Rory BDirector | SSaleClass A Ordinary Shares | −30.0K | $42.17 | −$1.27M | −6.6%421.7K after |
CBUS Cibus, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2023 (view filing) | Jun 1 | 1 day | Riggs Rory BChief Executive Officer | PPurchaseClass A Common Stock | +1.00K | $31.50 | +$31.5K | +0.1%1.15M after | From original |
| Dec 14, 2023 (view filing) | Dec 12 | 2 days | Riggs Rory BChief Executive Officer | PPurchaseClass A Common Stock | +517.1K | $10.58 | +$5.47M | +46.8%1.62M after |